Login
Newsletter

Subscribe now to our newsletter:



Related blogs
 

IP Policy Committee blog

URL: http://tacd-ip.org

Feed: http://tacd-ip.org/feed

Type: Individual

Last sync: 8 Hours, 23 Minutes ago

Google rank (beta): 0 / 10

Technorati authority: 0


Latest posts
“Can we afford our medicines?” November 12th event. NEW
IP Policy Committee blog 2 Weeks, 3 Days, 21 Hours, 29 Minutes ago
‘’Can we afford our medicines? The access to medicines crunch in Europe” European Parliament (room A3G-3), 12 November 2014, 12:30-15:00 We would like to invite you to the conference “Can we afford our medicines? The access to...
European Parliament event: “Can we afford our medicines?” November 12th NEW
IP Policy Committee blog 3 Weeks, 22 Hours, 16 Minutes ago
‘’Can we afford our medicines? The access to medicines crunch in Europe” European Parliament (room A3G-3), 12 November 2014, 12:30-15:00 We would like to invite you to the conference “Can we afford our medicines? The access to...
Notes on new EC Commissioners about access to knowledge NEW
IP Policy Committee blog 4 Weeks, 2 Days, 1 Hour, 54 Minutes ago
Notes on access to knowledge and IPR challenges of the new European Commission     Carlos Moedas, Commissioner for Research, Science and Innovation   It is generally accepted that copyright constitutes a barrier for EU researchers and...
Access to life saving medicines debate in plenary of European Parliament NEW
IP Policy Committee blog 1 Month, 1 Week, 6 Days, 15 Hours, 17 Minutes ago
European Parliament Strasbourg Plenary Session Subject: Commission statement – Access to life-saving medicines in Europe Date: September 16 2014   Connie Hedegaard, European Commissioner for Climate Action said that the Commission shared t...
Joint civil society letter to Juncker over placing pharmaceuticals under industry NEW
IP Policy Committee blog 1 Month, 1 Week, 6 Days, 17 Hours, 30 Minutes ago
Dear Mr. President-elect, We are writing to express our astonishment and concern regarding your decision to move the competence for medicinal products and health technologies from the Commissioner in charge of Health to the Commissioner in charge of...
Question and debate in EP (16-9-2014) on high prices of life-saving medicines NEW
IP Policy Committee blog 1 Month, 2 Weeks, 5 Days, 11 Hours, 53 Minutes ago
Oral Question posed by French MEP Michelle Rivasi (Greens) Access to medicines has repeatedly made the headlines in many EU countries over the past 3 months (in France, the UK, Spain, Greece, etc.). The reason for that is the price charged for Sofosb...
Gobal Broadcast Treaty and public interest NEW
IP Policy Committee blog 3 Months, 4 Weeks, 1 Day, 19 Hours, 29 Minutes ago
Statement to WIPO SCCR 28 on Broadcasting Treaty by TransAtlantic Consumer Dialogue     Broadcasting Treaty: Collateral damage to public access   Consumers and users around the world do not want new layers of complications, barriers an...
TRIPS, the European Commission and the European Medicines Agency´s clinical trial transparency policy NEW
IP Policy Committee blog 4 Months, 2 Weeks, 5 Days, 6 Hours, 32 Minutes ago
Nothing in international intellectual property law constitutes a serious barrier to the publication of clinical trial data for the sake of public health.   In his letter to the European Ombudsman dated 22 May 2014, the Director of the European M...
Human rights vs. patent monopolies on medicines in Greece NEW
IP Policy Committee blog 5 Months, 2 Weeks, 2 Days, 22 Hours, 56 Minutes ago
Human rights VS Patent Monopolies on medicines Written by Mr. Panayotis Kouroublis, Greek MP, SYRIZA parliamentary representative Published at http://www.koutipandoras.gr/article/113023/anthropina-dikaiomata-enantion-pneymatikon-dikaiomaton on 3 May...
EP Elections pledge: Europe for access to medicines and public health care NEW
IP Policy Committee blog 5 Months, 2 Weeks, 4 Days, 2 Minutes ago
10 commitments for candidates to the European Parliament 1. Defend universal access to public health care systems without discrimination for reasons of economic capacity, employment status or nationality. Support the principle of the integration of h...
Copyright meets broadcasting in Geneva NEW
IP Policy Committee blog 5 Months, 3 Weeks, 2 Days, 17 Hours, 8 Minutes ago
  The 27th session of the World Intellectual Property Organization´s Standing Committee on Copyright and Related Rights (SCCR) took place from 28 April to 2 May in Geneva. The Committee assessed the proposal for a Broadcasting Treaty. &nbs...
Copyright Treaty for Blind moves forward with EU signature and India´s ratification NEW
IP Policy Committee blog 5 Months, 3 Weeks, 5 Days, 48 Minutes ago
        On 30 April 2014, the Hellenic Presidency of the Council of the European Union, represented by the Ambassador of Greece to the UN in Geneva, Alexandros Alexandris signed the Treaty to Facilitate Access to Published Works b...
UFOS IN GENEVA NEW
IP Policy Committee blog 6 Months, 2 Days, 9 Hours, 1 Minute ago
      TACD oral statement to WIPO Standing Committee on Copyright and Related Rights     Before commenting the Broadcast Treaty I would like to congratulate the European Union and India for their signature tomorrow of the Mar...
A victory for medicine trial transparency but there is still a long way to go NEW
IP Policy Committee blog 6 Months, 3 Weeks, 6 Days, 16 Hours, 59 Minutes ago
      The European Parliament voted on Wednesday the adoption of the new Clinical Trials Regulation, which has removed the legal framework on commercial confidentiality that previously allowed pharma not to publish its data. With the n...
Students forge new thinking on access to medicines and innovation NEW
IP Policy Committee blog 9 Months, 1 Day, 9 Hours, 26 Minutes ago
  Universities Allied for Essential Medicines (UAEM) is a promising and inspiring international student network focusing on access to medicines and biomedical innovation. They have a  strong presence in the US and Germany and are growing al...
Patients before Patents – Response to The Economist by MSF and Oxfam NEW
IP Policy Committee blog 9 Months, 3 Days, 7 Hours, 49 Minutes ago
  Protect patients, not patents SIR – You argued that “protection should not be weakened” on pharmaceutical patents (“The new drugs war”, January 4th). Drug patents protect drug-companies’ profits, not patient...
FOR A TRANSPARENT, INNOVATIVE AND JUST RESPONSE TO THE CRISIS IN SPANISH PUBLIC HEALTHCARE” NEW
IP Policy Committee blog 9 Months, 1 Week, 1 Day, 7 Hours, 12 Minutes ago
NEW EXPERT AND CIVIL SOCIETY WORKING GROUP LAUNCH The Working Group on Health, Medicines, and Innovation has been launched with the goal of offering inclusive and constructive recommendations on the evaluation of health access, transparency, the mana...
Civil Society demands fair solutions to Greek health crisis NEW
IP Policy Committee blog 9 Months, 1 Week, 2 Days, 1 Hour, 7 Minutes ago
  There is a fully-fledged access to health care crisis in Greece as a result of the Troika-dictated cuts over the past four years. Three million people or more, exact figures are hard to get due to “Greek statistics”, have fallen of...
Notes from a generally non-informative “civil society” meeting on TTIP NEW
IP Policy Committee blog 9 Months, 2 Weeks, 6 Hours, 49 Minutes ago
  Brief chronicle of an obscure, scarcely informative “civil society” meeting on the TransAtlantic Trade and Investment Partnership in Brussels on January 14th, 2014   A few tidbits of Commission statements:   The European...
Big Pharma´s leaked wish list for TTIP EU-US trade pact NEW
IP Policy Committee blog 9 Months, 2 Weeks, 7 Hours, 22 Minutes ago
PhRMA/EFPIA priorities for TTIP. I. Regulatory issues : Greater regulatory convergence: Ø  a built-in agenda allowing for progressive greater regulatory convergence over time. Ø  a Working Group on Pharmaceutical and Medical D...